es > en

> Specialties and products

Inflammatory Bowel Disease IBD

Two million people in Europe suffer from inflammatory bowel disease (IBD). Crohn 's disease and ulcerative colitis are chronic diseases that affect the intestinal tract and whose symptoms are difficult to distinguish from Irritable Bowel Syndrome

Fecal calprotectin is a marker that allows the physician decide whether a patient should be treated for the symptoms of Inflammatory Bowel Syndrome IBS or should be referred to perform invasive tests (colonoscopy ) for diagnosis of Crohn's disease or ulcerative colitis .

The clinical course of patients with inflammatory bowel disease IBD is characterized by periods of remission with intermittent outbreaks characterized by inflammation of the intestine.

Fecal calprotectin is an excellent predictor of relapses in patients with Crohn's disease and ulcerative colitis and is an effective and non-invasive tool that can predict the severity of the outbreak and tailor treatment to patients.

Palex Medical offers different methods for quantitative determination of fecal calprotectin oriented laboratory, clinical specialists ( gastroenterologists and pediatricians ) and even patients
 

> Share in